Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.10
-0.15 (-1.46%)
Mar 9, 2026, 4:25 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 53.25 million as of March 9, 2026. Its market cap has increased by 16.50% in one year.
Market Cap
53.25M
Enterprise Value
50.57M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.10
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 53.25M, a decrease of -52.81%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 53.25M | 37.00% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 56.47M |
| Faron Pharmaceuticals Oy | 61.94M |
| Hemogenyx Pharmaceuticals | 67.47M |
| ImmuPharma | 35.19M |
| Bioventix | 80.99M |
| 4basebio | 83.58M |
| SkinBioTherapeutics | 32.40M |
| Poolbeg Pharma | 29.61M |